Control of caspase activation in apoptosis
Control of caspase activation in apoptosis
批准号:
8298331
负责人:
Sally A Kornbluth
金额:
$32.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-21 至 2016-02-29
关键词:
AcetylationAgeApoptosisApoptoticBindingBirthBreast Cancer CellCa(2+)-Calmodulin Dependent Protein KinaseCalciumCalmodulinCaspaseCell DeathCell SurvivalCellsCessation of lifeChemotherapy-Oncologic ProcedureDataDeacetylaseDeacetylationDevelopmentDimerizationEnvironmentExcisionFailureFemaleGlucoseGlucose-6-PhosphateGoalsGrantImmune systemIndividualLifeLinkLongevityMalignant NeoplasmsMenopauseMetabolicMetabolismModelingMolecularMusNADPNutrientOocytesPathway interactionsPentosephosphate PathwayPeptide HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPlayPredispositionProtein DephosphorylationProtein phosphataseProteinsRadiationResistanceRoleSignal TransductionSiteSomatic CellTherapeuticTimeTissuesVertebratesWomanWorkXenopus oocytecancer cellcancer therapycaspase-2cell injurycell suicidechemotherapeutic agentchemotherapyglucose metabolismhuman femaleinsightpreventpro-caspase-2programsresponsestemstressortransmission process
中文摘要
描述(由申请人提供):细胞凋亡导致的细胞死亡导致单个细胞从活组织中移除,而不会损害周围组织。近年来,人们认识到对细胞凋亡的抵抗是癌症的一个标志,对化疗的抵抗可能源于细胞凋亡信号传递的失败。我们已经发现,高水平的葡萄糖代谢,就像在癌细胞中看到的那样,可以有效地抑制细胞凋亡。特别是,我们发现引发剂caspase, caspase 2 (C2),在对许多化疗药物的反应中被激活,当戊糖磷酸途径(PPP)活性高时被抑制。我们发现,大量的NADPH,由PPP产生,促进激酶CaMKII活化磷酸化和抑制C2。小酸性蛋白14-3-3?阻止C2去磷酸化、二聚化和活化。相反,当葡萄糖或其他营养物质稀缺时,14-3-3 ?从C2释放,允许去磷酸化和激活。我们最近发现14- 3-3 ?当营养物质耗尽时,与C2的结合受到乙酰化的阻碍(因此PPP不能运作),14-3-3 ?在营养充足的条件下,由Sirt1催化的去乙酰化受到刺激。该基金的目的是:1)描绘连接NADPH和CaMKII的分子途径;2)确定Sirt1如何被调节以控制14-3-3 ?3)确定乳腺癌细胞的化学反应性是否可以通过操纵连接代谢和C2的途径来改变。
英文摘要
DESCRIPTION (provided by applicant): Cell death by apoptosis results in the removal of individual cells from the midst of a living tissue without damage to surrounding tissue. In recent years, it has been recognized that resistance to apoptosis is a hallmark of cancers and that resistance to chemotherapy can stem from a failure in apoptotic signal transmission. We have found that high levels of glucose metabolism, as is typically seen in cancer cells, can potently suppress apoptosis. In particular, we have found that the initiator caspase, caspase 2 (C2), activated in response to a number of chemotherapeutic agents, is suppressed when pentose phosphate pathway (PPP) activity is high. We have found that abundant NADPH, produced by the PPP, promotes activation of the kinase CaMKII to phosphorylate and suppress C2. Binding of phosphorylated C2 by the small acidic protein 14-3-3? prevents C2 dephosphorylation, dimerization, and activation. Conversely, when glucose or other nutrients are scarce, 14-3-3 ? is released from C2 to allow dephosphorylation and activation. We have recently found that 14- 3-3 ? binding to C2 is impeded by acetylation when nutrients are depleted (so that the PPP cannot operate) and that 14-3-3 ? deacetylation, catalyzed by the sirtuin, Sirt1, is stimulated under nutrient replete conditions. The aims of this grant are 1) to delineate the molecular pathways linking NADPH and CaMKII, 2) to determine how Sirt1 is regulated to control 14-3-3 ?-C2 interactions and 3) to determine whether chemoresponsiveness of breast cancer cells can be altered by manipulating the pathways linking metabolism and C2.
PUBLIC HEALTH RELEVANCE: The goal of this grant is to determine how metabolism regulates the apoptotic protease, caspase 2 and to determine how metabolic manipulation might be used to enhance caspase-2 activation. As caspase 2 has been implicated in the response to some chemotherapeutic agents, this work may provide avenues for enhancing the response to cancer chemotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering tyrosine kinase-activated caspases for selective cancer cell killing
-
批准号:8118973
-
项目类别:
-
资助金额:$24.69万
-
财政年份:2010
-
负责人:Sally A Kornbluth
-
依托单位:
Engineering tyrosine kinase-activated caspases for selective cancer cell killing
-
批准号:8490683
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2010
-
负责人:Sally A Kornbluth
-
依托单位:
Engineering tyrosine kinase-activated caspases for selective cancer cell killing
-
批准号:8259784
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2010
-
负责人:Sally A Kornbluth
-
依托单位:
Regulation of M phase exit
-
批准号:7933641
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2009
-
负责人:Sally A Kornbluth
-
依托单位:
Control of caspase activation in apoptosis
-
批准号:7919777
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2009
-
负责人:Sally A Kornbluth
-
依托单位:
Control of caspase activation in apoptosis
-
批准号:7364366
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2007
-
负责人:Sally A Kornbluth
-
依托单位:
Control of caspase activation in apoptosis
-
批准号:7498976
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2007
-
负责人:Sally A Kornbluth
-
依托单位:
Control of caspase activation in apoptosis
-
批准号:7678370
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2007
-
负责人:Sally A Kornbluth
-
依托单位:
Control of caspase activation in apoptosis
-
批准号:8466986
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2007
-
负责人:Sally A Kornbluth
-
依托单位:
Control of caspase activation in apoptosis
-
批准号:7914376
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2007
-
负责人:Sally A Kornbluth
-
依托单位:
Inhibition of Cytochrome c-induced Caspase Activation
-
批准号:6912548
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Control of Mitotic Entry by Regulators of Cdc2
-
批准号:6792592
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Control of Mitotic Entry by Regulators of Cdc2
-
批准号:6688033
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Inhibition of Cytochrome c-induced Caspase Activation
-
批准号:8433980
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Inhibition of Cytochrome c-induced Caspase Activation
-
批准号:8610138
-
项目类别:
-
资助金额:$25.52万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Inhibition of Cytochrome c-induced Caspase Activation
-
批准号:8018154
-
项目类别:
-
资助金额:$26.31万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Control of Mitotic Entry by Regulators of Cdc2
-
批准号:7104926
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Control of Mitotic Entry by Regulators of Cdc2
-
批准号:7314425
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Inhibition of Cytochrome c-induced Caspase Activation
-
批准号:6769326
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
Inhibition of Cytochrome c-induced Caspase Activation
-
批准号:7789967
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2003
-
负责人:Sally A Kornbluth
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: